Blog

  • Home
  • Blog
  • Reduced experimental work by 4 compared to DoE for an oligonucleotide ion exchange process

Reduced experimental work by 4 compared to DoE for an oligonucleotide ion exchange process

Customer Success Story from GSK

  • by Ypso-Facto
  • December 18, 2023
Reduced experimental work by 4 compared to DoE for an oligonucleotide ion exchange process

"GSK Engaged Ypso-Facto’s expertise, their Ypso-Ionic software and GPX approach to develop a mechanistic model of a complex ion-exchange purification process.  

Compared with the classical statistical DoE approach, only 25% of the experimental work was required, but we also achieved much more, including deep process understanding, troubleshooting, identification of trends and associated design space as well as multicolumn chromatography predesign.  

In addition to the technical project work, Ypso-Facto’s highly collaborative ways of working have increased our organizational expertise and allowed us to demonstrate the value of mechanistic modelling"

Chris MCKAY, Principal Process Engineer, GSK 

For more insights on our project with GSK, read these articles:


Ypso-Facto is a service company helping industrial firms to develop, optimize and secure their chemical processes and bioprocesses.

Learn more

Contact Us
  • Address: 19 avenue Foch
    54000 NANCY - FRANCE
  • LU +352 20 21 39 14
    FR +33(0) 355 961 650
  • contact@ypso-facto.com
© Ypso-Facto 2014 - Powered by Ealys | Legal Information